Pancreatic Cancer Research

ResearcherYokohama City UniversityActive in the last 2 years

Takashi Oshima

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-5818-8649; OpenAlex author ID A5090217118. Sources: OpenAlex.

Their work

Papers
15 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
20
Papers, trials and grants by year

2015: 2 papers · 2016: 2 papers · 2017: 3 papers · 2018: 2 papers · 2019: none · 2020: 2 papers · 2021: none · 2022: none · 2023: 2 papers · 2024: 2 papers

Papers 15

  1. Clinical Impact of Preoperative Neutrophil-to-Lymphocyte Ratio in Surgical Patients With Pancreatic Cancer. Co-author DOI 10.21873/anticanres.16805↗
  2. Clinical Impact of Preoperative Prognostic Nutritional Index in Surgical Patients With Pancreatic Cancer Treated With Perioperative Adjuvant Chemotherapy. Co-author DOI 10.21873/anticanres.16970↗
  3. Carbon Ion Radiotherapy Versus Perioperative Adjuvant Chemotherapy and Curative Surgery for Resectable Pancreatic Cancer. First author DOI 10.21873/anticanres.16222↗
  4. Clinical Impact of Nutrition and Inflammation Assessment Tools in Pancreatic Cancer Treatment. Last author DOI 10.21873/anticanres.16572↗
  5. Novel targets identified by integrated cancer-stromal interactome analysis of pancreatic adenocarcinoma. Co-author DOI 10.1016/j.canlet.2019.10.031↗
  6. The age-adjusted Charlson comorbidity index is an independent prognostic factor in pancreatic cancer patients who receive curative resection followed by adjuva… Co-author DOI 10.4103/jcrt.jcrt_440_18↗
  7. The Lymph Node Ratio Is an Independent Prognostic Factor in Pancreatic Cancer Patients Who Receive Curative Resection Followed by Adjuvant Chemotherapy. Co-author DOI 10.21873/anticanres.12801↗
  8. Survival and the prognosticators of peritoneal cytology-positive pancreatic cancer patients undergoing curative resection followed by adjuvant chemotherapy. Co-author DOI 10.4103/0973-1482.194927↗
  9. Clinical implications of ribonucleotide reductase subunit M1 in patients with pancreatic cancer who undergo curative resection followed by adjuvant chemotherap… Co-author DOI 10.3892/ol.2017.5935↗
  10. Predictive role of human equilibrative nucleoside transporter 1 in patients with pancreatic cancer treated by curative resection and gemcitabine-only adjuvant … Co-author DOI 10.3892/ol.2017.6220↗
  11. Clinical implications of dihydropyrimidine dehydrogenase expression in patients with pancreatic cancer who undergo curative resection with S-1 adjuvant chemoth… Co-author DOI 10.3892/ol.2017.6295↗
  12. The Surgical Apgar Score Is an Independent Prognostic Factor in Patients with Pancreatic Cancer Undergoing Pancreatoduodenectomy Followed by Adjuvant Chemother… Co-author PMID 27127164↗
  13. [Safety and Feasibility of Pancreatic Surgery for Pancreatic Cancer in Elderly Patients]. Co-author PMID 28133043↗
  14. Safety and feasibility of S-1 adjuvant chemotherapy for pancreatic cancer in elderly patients. Co-author DOI 10.1007/s00280-015-2736-5↗
  15. [The Safety and Feasibility of Conversion Surgery for Initially Unresectable Pancreatic Cancer]. Co-author PMID 26805070↗

Closest collaborators

The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Soichiro Morinaga · 14 shared papers, 2015–2024 · strength 1.20
  2. Masaaki Murakawa · 13 shared papers, 2015–2024 · strength 1.10
  3. Makoto Ueno · 12 shared papers, 2015–2024 · strength 1.06
  4. Naoto Yamamoto · 10 shared papers, 2015–2024 · strength 0.96
  5. Toru Aoyama · 12 shared papers, 2015–2024 · strength 0.91
  6. Satoshi Kobayashi · 8 shared papers, 2015–2024 · strength 0.71
  7. Manabu Morimoto · 9 shared papers, 2015–2020 · strength 0.53
  8. Yuto Kamioka · 3 shared papers, 2023–2024 · strength 0.52
  9. Shinnosuke Kawahara · 3 shared papers, 2023–2024 · strength 0.52
  10. Hiroshi Tamagawa · 3 shared papers, 2018–2024 · strength 0.32
  11. Mariko Kamiya · 3 shared papers, 2018–2024 · strength 0.32
  12. Yohei Miyagi · 4 shared papers, 2017–2020 · strength 0.27
  13. Toru Aoyama · 1 shared paper, 2023 · strength 0.24
  14. Hiroyuki Katoh · 1 shared paper, 2023 · strength 0.18
  15. Masakatsu Numata · 2 shared papers, 2018–2020 · strength 0.16
  16. Michael Bouvet · 1 shared paper, 2020 · strength 0.10
  17. Yasushi Ichikawa · 1 shared paper, 2020 · strength 0.10
  18. Yukihiko Hiroshima · 1 shared paper, 2020 · strength 0.10
  19. Robert M. Hoffman · 1 shared paper, 2020 · strength 0.10
  20. Itaru Endo · 1 shared paper, 2020 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.